Profile
TAK ZTS HLN TEVA ITCI RDY
Company Name Takeda Pharmaceutical Company Limited Zoetis Inc. Haleon plc Teva Pharmaceutical Industries Limited Intra-Cellular Therapies, Inc. Dr. Reddy's Laboratories Limited
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic
Market Cap $47.84B $73.16B $46.83B $19.50B $14.05B $12.67B
Employees 49.28K 13.80K 24.56K 37.00K 0.86K 27.05K
CEO Mr. Christophe Weber Ms. Kristin C. Peck Mr. Brian James McNamara Richard D. Francis Dr. Sharon Mates Ph.D. Mr. Erez Israeli M.B.A.
Ratings
TAK ZTS HLN TEVA ITCI RDY
Quant Rating Score 3 3 3 1 1 3
Quant Rating Neutral Neutral Neutral Strong Sell Strong Sell Neutral
Trading
TAK ZTS HLN TEVA ITCI RDY
Last Close $14.97 $157.23 $10.5 $17 $131.87 $15.5
High 52 $15.39 $196.48 $11.41 $22.77 $131.91 $84.21
Low 52 $12.89 $144.45 $8.26 $12.82 $67.99 $12.36
Price vs. 52 Week High -2.73 % -19.98 % -7.98 % -25.34 % -0.03 % -81.59 %
Price vs. 52 Week Low 16.14 % 8.85 % 27.12 % 32.61 % 93.95 % 25.4 %
Total Return
TAK ZTS HLN TEVA ITCI RDY
1 Month Return 2.75 % -3.29 % -5.75 % 0.24 % 0 % 7.79 %
3 Month Return -0.33 % -3.43 % 4.48 % 8.35 % 0.14 % 16.63 %
6 Month Return 13.93 % -5.01 % 7.8 % -24.85 % 53.34 % -0.45 %
9 Month Return 2.18 % -19.32 % -0.85 % -4.17 % 80.13 % -80.61 %
YTD Return 13.07 % -3.5 % 10.06 % -22.87 % 57.89 % -1.84 %
1 Year Return 15.87 % -8 % 23.53 % 4.62 % 85.5 % -78.48 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
TAK ZTS HLN TEVA ITCI RDY
Dividend Yield Percentage (TTM) 4.52 % 1.13 % 0.01 % - - 0.61 %
Dividend Paid and Capex Coverage Ration (TTM) 1.65 % 2 % - 2.53 % -227.26 % 1.23 %
Dividend Per Share (TTM) 196 % 1.86 % 0.05 % - - 8 %
Payout Ratio (TTM) 280.28 % 32.25 % - - - 11.78 %
Profitability
TAK ZTS HLN TEVA ITCI RDY
Gross Profit Margin TTM 54.7 % 70.2 % 61.52 % 49.17 % 91.63 % 57.17 %
Return on Assets TTM 0.76 % 17.86 % 4.2 % -3.35 % -5.46 % 11.47 %
Return on Equity TTM 1.48 % 51.32 % 8.73 % -21.38 % -7.4 % 18.08 %
Return on Capital Employed TTM 3.75 % 32.08 % 7.74 % 1.59 % -10.05 % 19.71 %
Net Income Per EBT TTM 61.12 % 78.79 % 75.5 % 246.36 % 100.64 % 73.7 %
EBT Per Ebit TTM 40.08 % 92.99 % 86.58 % -120.28 % 63.57 % 107.37 %
EBIT Per Revenue TTM 9.62 % 37.01 % 19.64 % 2.61 % -17.15 % 21.95 %
Cash Flow To Debt Ratio TTM 21.32 % 43.63 % - 7.47 % -430.93 % 98.64 %
Receivables Turnover TTM 6.32 6.82 5.9 4.91 4.09 3.6
Payables Turnover TTM 4.36 6.51 2.19 3.69 2.18 3.92
Inventory Turnover TTM 1.7 1.16 3.63 2.6 2.17 1.96
Fixed Asset Turnover TTM 232.78 % 253.65 % 584.75 % 332.7 % 4569.25 % 332.99 %
Asset Turnover TTM 32.15 % 65.87 % 32.73 % 43.25 % 49.79 % 66.03 %
Operating Cash Flow Per Share TTM 608.55 6.58 - 1.11 -0.71 276.98
Free Cash Flow Per Share TTM 443.26 5.1 - 0.67 -0.71 91.96
Cash Per Share TTM 24349.44 % 384.5 % 24.05 % 149.12 % 970.67 % 34770.1 %
Operating Cash Flow Sales Ratio TTM 21.01 % 31.71 % - 7.62 % -10.75 % 14.17 %
Free Cash Flow Operating Cash Flow Ratio TTM 72.84 % 77.45 % - 60.43 % 100.44 % 33.2 %
Cash Flow Coverage Ratios TTM 21.32 % 43.63 % - 7.47 % -430.93 % 98.64 %
Price To Free Cash Flows Ratio TTM 9.73 32.07 - 25.68 -191.12 71.73
Price To Operating Cash Flows Ratio TTM 7.13 24.98 - 15.4 -185.85 4.77
Price Cash Flow Ratio TTM 7.13 24.98 - 15.4 -185.85 4.77
Income Statement (TTM)
TAK ZTS HLN TEVA ITCI RDY
Revenue $4263.76B $9.26B $11.23B $16.54B $0.68B $325.54B
Gross Profit $2832.26B $6.54B $6.95B $8.06B $0.62B $190.43B
Gross Profit Ratio 66.43% 70.62% 61.85% 48.74% 91.63% 58.5%
EBITDA $874.6B $3.87B $2.51B $0.72B $-0.12B $96.67B
Net Income $144.07B $2.49B $1.44B $-1.64B $-0.07B $56.54B
EPS Diluted 45.58 5.47 0.32 -1.45 -0.72 -
Balance Sheet (MRQ)
TAK ZTS HLN TEVA ITCI RDY
Long Term Debt $5029.93B $5.39B $8.54B $16.3B $0.01B $7.86B
Total Liabilities $7834.79B $9.47B $18.09B $33.61B $0.22B $155.82B
Total Equity $7274.01B $4.77B $16.22B $5.72B $1.15B $337.17B
Total Investments $445.7B $0B $0.08B $0B $0.69B $58.46B
Total Debt $4843.75B $6.74B $10.1B $18.08B $0.02B $46.77B
Total Assets $15108.79B $14.24B $34.32B $39.33B $1.37B $492.99B
Cash Flow Statement (TTM)
TAK ZTS HLN TEVA ITCI RDY
Net Income $144.07B $2.5B $1.44B $-1.96B $-0.07B $57.25B
Inventory $-115.74B $-0.04B $0.22B $0.17B $-0.01B $-12.75B
Dividends Paid $-287.19B $-0.79B $-0.57B $0B $0B $-6.66B
Operating Cash Flow $716.34B $2.95B $2.3B $1.25B $-0.07B $46.43B
Capital Expenditure $-480.73B $-0.66B $-0.25B $-0.5B $-0B $-34.4B
Related Stocks
Ticker Name Price
ACB Aurora Cannabis Inc. 4.26
ACOR Acorda Therapeutics, Inc. 0.661
ACRX AcelRx Pharmaceuticals, Inc. 0.86
ADMP Adamis Pharmaceuticals Corporation 0.775
ADMS Adamas Pharmaceuticals, Inc. 8.22
AERI Aerie Pharmaceuticals, Inc. 15.25
AGRX Agile Therapeutics, Inc. 1.51
AKAN Akanda Corp. 1.45
ALIM Alimera Sciences, Inc. 5.54
ALVO Alvotech 9.42
ALVOW Alvotech 1.7
AMPH Amphastar Pharmaceuticals, Inc. 23.18
AMRX Amneal Pharmaceuticals, Inc. 8.13
AMYT Amryt Pharma plc 14.7
ANIP ANI Pharmaceuticals, Inc. 65.81
APUS Apimeds Pharmaceuticals US, Inc 1.7183
AQST Aquestive Therapeutics, Inc. 3.25
ASRT Assertio Holdings, Inc. 0.6509
ATNX Athenex, Inc. 0.2031
AVDL Avadel Pharmaceuticals plc 9.29
ETFs With Exposure to TAK
Ticker ETF Name Weight Percentage Price
VEU Vanguard FTSE All-World ex-US Index Fund 0 66.76
FVD First Trust Value Line Dividend Index Fund 0.46 44.36
CVY Invesco Zacks Multi-Asset Income ETF 0.446 25.69
GCOW Pacer Global Cash Cows Dividend ETF 0.74 37.79
AFTY Pacer CSOP FTSE China A50 ETF 0.27 16.2826
AGGY WisdomTree Yield Enhanced U.S. Aggregate Bond Fund 0.04 43.525
FPXI First Trust International Equity Opportunities ETF 2.11 55.74
ICOW Pacer Developed Markets International Cash Cows 100 ETF 1.77 33.93
PPH VanEck Pharmaceutical ETF 2.86 87.93
VETS Pacer Military Times Best Employers ETF 0.18 38.62
ACSG Xtrackers MSCI ACWI ex USA ESG Leaders Equity ETF 0.37 33.28
PTIN Pacer Trendpilot International ETF 0.18 28.5886
VALT ETFMG Sit Ultra Short ETF 0.77 48.52
SLT Pacer Salt High truBeta US Market ETF 0.18 39.22
LSLT Pacer Salt Low truBeta US Market ETF 0.18 32
AVDE Avantis International Equity ETF 0.07 73.35
GERM ETFMG Treatments, Testing and Advancements ETF 0.89 19.1577
VIRS Pacer BioThreat Strategy ETF 0.18 40.025
FVL First Trust Value Line 100 Exchange-Traded Fund 0.46 23.1559
SILX ETFMG Prime 2x Daily Junior Silver Miners ETF 0.73 1.75
RTL The Necessity Retail REIT, Inc. 0.27 7.61
BAD B.A.D. ETF 1.51 11.91
AVSD Avantis Responsible International Equity ETF 0.07 66.8427
DFIC Dimensional International Core Equity 2 ETF 0.00110528 30.77
VFWAX Vanguard FTSE All-World ex-US Index Fd Admiral 0 41.47
DFAX Dimensional World ex U.S. Core Equity 2 ETF 0.00091701 29.14
TRPL Pacer Metaurus US Large Cap Dividend Multiplier 300 ETF 0.18 41.14
OZEM Roundhill GLP-1 & Weight Loss ETF 1.92 25.2788
CGCV Capital Group Conservative Equi 0.1 28.48
ENDW Cambria Endowment Style ETF 0 27.7932
Unlock